594 related articles for article (PubMed ID: 26661515)
1. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
[TBL] [Abstract][Full Text] [Related]
2. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.
Whitman E; Barber A
Mol Immunol; 2015 Feb; 63(2):268-78. PubMed ID: 25089028
[TBL] [Abstract][Full Text] [Related]
3. NKG2D- and CD28-mediated costimulation regulate CD8+ T cell chemotaxis through different mechanisms: the role of Cdc42/N-WASp.
Serrano-Pertierra E; Cernuda-Morollón E; López-Larrea C
J Leukoc Biol; 2014 Mar; 95(3):487-95. PubMed ID: 24168855
[TBL] [Abstract][Full Text] [Related]
4. Functional dichotomy between NKG2D and CD28-mediated co-stimulation in human CD8+ T cells.
Rajasekaran K; Xiong V; Fong L; Gorski J; Malarkannan S
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844584
[TBL] [Abstract][Full Text] [Related]
5. mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells.
Ito D; Nojima S; Nishide M; Okuno T; Takamatsu H; Kang S; Kimura T; Yoshida Y; Morimoto K; Maeda Y; Hosokawa T; Toyofuku T; Ohshima J; Kamimura D; Yamamoto M; Murakami M; Morii E; Rakugi H; Isaka Y; Kumanogoh A
J Immunol; 2015 Aug; 195(3):934-43. PubMed ID: 26116513
[TBL] [Abstract][Full Text] [Related]
6. IL-12 Influence mTOR to Modulate CD8
Wang H; Li J; Han Q; Yang F; Xiao Y; Xiao M; Xu Y; Su L; Cui N; Liu D
Int J Med Sci; 2017; 14(10):977-983. PubMed ID: 28924369
[No Abstract] [Full Text] [Related]
7. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
[TBL] [Abstract][Full Text] [Related]
8. NKG2D induces Mcl-1 expression and mediates survival of CD8 memory T cell precursors via phosphatidylinositol 3-kinase.
Wensveen FM; Lenartic M; Jelencic V; Lemmermann NA; ten Brinke A; Jonjic S; Polic B
J Immunol; 2013 Aug; 191(3):1307-15. PubMed ID: 23804716
[TBL] [Abstract][Full Text] [Related]
9. Expression of NKG2D and CD107 in CD8(+) effector memory lymphocytes in Churg-Strauss syndrome.
Boita M; Rolla G; Mallone R; Martinuzzi E; Heffler E; Circosta P; Elia AR; Cignetti A; Caillat-Zucman S; de Menthon M; Guida G
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S57-61. PubMed ID: 22640649
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function.
Zhang L; Tschumi BO; Corgnac S; Rüegg MA; Hall MN; Mach JP; Romero P; Donda A
J Immunol; 2014 Aug; 193(4):1759-65. PubMed ID: 25015820
[TBL] [Abstract][Full Text] [Related]
11. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
[TBL] [Abstract][Full Text] [Related]
12. CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells.
Altvater B; Pscherer S; Landmeier S; Niggemeier V; Juergens H; Vormoor J; Rossig C
Clin Exp Immunol; 2006 Jun; 144(3):447-57. PubMed ID: 16734614
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
14. The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitis.
Kennedy PT; Gehring AJ; Nowbath A; Selden C; Quaglia A; Dhillon A; Dusheiko G; Bertoletti A
J Viral Hepat; 2008 Dec; 15(12):901-9. PubMed ID: 19087227
[TBL] [Abstract][Full Text] [Related]
15. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
[TBL] [Abstract][Full Text] [Related]
16. T cell receptor-mediated activation is a potent inducer of macroautophagy in human CD8(+)CD28(+) T cells but not in CD8(+)CD28(-) T cells.
Arnold CR; Pritz T; Brunner S; Knabb C; Salvenmoser W; Holzwarth B; Thedieck K; Grubeck-Loebenstein B
Exp Gerontol; 2014 Jun; 54():75-83. PubMed ID: 24468331
[TBL] [Abstract][Full Text] [Related]
17. TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.
Matsuzawa Y; Oshima S; Takahara M; Maeyashiki C; Nemoto Y; Kobayashi M; Nibe Y; Nozaki K; Nagaishi T; Okamoto R; Tsuchiya K; Nakamura T; Ma A; Watanabe M
Autophagy; 2015; 11(7):1052-62. PubMed ID: 26043155
[TBL] [Abstract][Full Text] [Related]
18. Regulation of RLR-Mediated Antiviral Responses of Human Dendritic Cells by mTOR.
Fekete T; Ágics B; Bencze D; Bene K; Szántó A; Tarr T; Veréb Z; Bácsi A; Pázmándi K
Front Immunol; 2020; 11():572960. PubMed ID: 33013932
[TBL] [Abstract][Full Text] [Related]
19. NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.
Zloza A; Kohlhapp FJ; Lyons GE; Schenkel JM; Moore TV; Lacek AT; O'Sullivan JA; Varanasi V; Williams JW; Jagoda MC; Bellavance EC; Marzo AL; Thomas PG; Zafirova B; Polić B; Al-Harthi L; Sperling AI; Guevara-Patiño JA
Nat Med; 2012 Feb; 18(3):422-8. PubMed ID: 22366950
[TBL] [Abstract][Full Text] [Related]
20. TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1.
Sabins NC; Chornoguz O; Leander K; Kaplan F; Carter R; Kinder M; Bachman K; Verona R; Shen S; Bhargava V; Santulli-Marotto S
J Immunol; 2017 Dec; 199(12):4091-4102. PubMed ID: 29127145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]